Search by Drug Name or NDC
NDC 41167-4232-06 Childrens Allegra Allergy 30 mg/1 Details
Childrens Allegra Allergy 30 mg/1
Childrens Allegra Allergy is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN OTC DRUG category. It is labeled and distributed by Chattem, Inc.. The primary component is FEXOFENADINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Fexofenadine is used to relieve the allergy symptoms of seasonal allergic rhinitis (''hay fever''), including runny nose; sneezing; red, itchy, or watery eyes; or itching of the nose, throat, or roof of the mouth in adults and children 2 years of age and older. It is also used to relieve symptoms of urticaria (hives; red, itchy raised areas of the skin), including itching and rash in adults and children 6 months of age and older. Fexofenadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms.
Related Packages: 41167-4232-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fexofenadine
Product Information
| NDC | 41167-4232 |
|---|---|
| Product ID | 41167-4232_97ef9dd3-6eba-4189-80d0-c861c1fcf16c |
| Associated GPIs | 41550024107210 |
| GCN Sequence Number | 062959 |
| GCN Sequence Number Description | fexofenadine HCl TAB RAPDIS 30 MG ORAL |
| HIC3 | Z2Q |
| HIC3 Description | ANTIHISTAMINES - 2ND GENERATION |
| GCN | 98722 |
| HICL Sequence Number | 011595 |
| HICL Sequence Number Description | FEXOFENADINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Childrens Allegra Allergy |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fexofenadine Hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | FEXOFENADINE HYDROCHLORIDE |
| Labeler Name | Chattem, Inc. |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021909 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 41167-4232-06 (41167423206)
| NDC Package Code | 41167-4232-6 |
|---|---|
| Billing NDC | 41167423206 |
| Package | 4 BLISTER PACK in 1 CARTON (41167-4232-6) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Marketing Start Date | 2014-01-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 06115cea-5a44-409d-85ed-bb71743491c1 Details
Uses
Warnings
Ask a doctor before use if you have
kidney disease. Your doctor should determine if you need a different dose.
When using this product
- do not take more than directed
- do not take at the same time as aluminum or magnesium antacids
- do not take with fruit juices (see Directions)
Directions
- place 1 tablet on tongue; tablet disintegrates, with or without water
| adults and children 12 years of age and over | take 2 tablets every 12 hours on an empty stomach; do not take more than 4 tablets in 24 hours |
| children 6 to under 12 years of age | take 1 tablet every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hours |
| children under 6 years of age | do not use |
| adults 65 years of age and older | ask a doctor |
| consumers with kidney disease | ask a doctor |
Other information
Inactive ingredients
Questions or comments?
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
| CHILDRENS ALLEGRA ALLERGY
fexofenadine hydrochloride tablet, orally disintegrating |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - Chattem, Inc. (003336013) |
Revised: 8/2022
Document Id: 97ef9dd3-6eba-4189-80d0-c861c1fcf16c
Set id: 06115cea-5a44-409d-85ed-bb71743491c1
Version: 13
Effective Time: 20220829